37298510|t|Effectiveness of Combinational Treatments for Alzheimer's Disease with Human Neural Stem Cells and Microglial Cells Over-Expressing Functional Genes.
37298510|a|Alzheimer's disease (AD) is one of the most common neurodegenerative diseases. In AD patients, amyloid-beta (Abeta) peptide-mediated degeneration of the cholinergic system utilizing acetylcholine (ACh) for memory acquisition is observed. Since AD therapy using acetylcholinesterase (AChE) inhibitors are only palliative for memory deficits without reversing disease progress, there is a need for effective therapies, and cell-based therapeutic approaches should fulfil this requirement. We established F3.ChAT human neural stem cells (NSCs) encoding the choline acetyltransferase (ChAT) gene, an ACh-synthesizing enzyme, HMO6.NEP human microglial cells encoding the neprilysin (NEP) gene, an Abeta-degrading enzyme, and HMO6.SRA cells encoding the scavenger receptor A (SRA) gene, an Abeta-uptaking receptor. For the efficacy evaluation of the cells, first, we established an appropriate animal model based on Abeta accumulation and cognitive dysfunction. Among various AD models, intracerebroventricular (ICV) injection of ethylcholine mustard azirinium ion (AF64A) induced the most severe Abeta accumulation and memory dysfunction. Established NSCs and HMO6 cells were transplanted ICV to mice showing memory loss induced by AF64A challenge, and brain Abeta accumulation, ACh concentration and cognitive function were analyzed. All the transplanted F3.ChAT, HMO6.NEP and HMO6.SRA cells were found to survive up to 4 weeks in the mouse brain and expressed their functional genes. Combinational treatment with the NSCs (F3.ChAT) and microglial cells encoding each functional gene (HMO6.NEP or HMO6.SRA) synergistically restored the learning and memory function of AF64A-challenged mice by eliminating Abeta deposits and recovering ACh level. The cells also attenuated inflammatory astrocytic (glial fibrillary acidic protein) response by reducing Abeta accumulation. Taken together, it is expected that NSCs and microglial cells over-expressing ChAT, NEP or SRA genes could be strategies for replacement cell therapy of AD.
37298510	46	65	Alzheimer's Disease	Disease	MESH:D000544
37298510	71	76	Human	Species	9606
37298510	150	169	Alzheimer's disease	Disease	MESH:D000544
37298510	171	173	AD	Disease	MESH:D000544
37298510	201	227	neurodegenerative diseases	Disease	MESH:D019636
37298510	232	234	AD	Disease	MESH:D000544
37298510	235	243	patients	Species	9606
37298510	332	345	acetylcholine	Chemical	MESH:D000109
37298510	347	350	ACh	Chemical	MESH:D000109
37298510	394	396	AD	Disease	MESH:D000544
37298510	411	431	acetylcholinesterase	Gene	43
37298510	433	437	AChE	Gene	43
37298510	474	489	memory deficits	Disease	MESH:D008569
37298510	660	665	human	Species	9606
37298510	704	729	choline acetyltransferase	Gene	1103
37298510	731	735	ChAT	Gene	1103
37298510	746	749	ACh	Chemical	MESH:D000109
37298510	771	779	HMO6.NEP	CellLine	CVCL:5G94
37298510	780	785	human	Species	9606
37298510	816	826	neprilysin	Gene	4311
37298510	828	831	NEP	Gene	4311
37298510	870	878	HMO6.SRA	CellLine	CVCL:5G94
37298510	898	918	scavenger receptor A	Gene	4481
37298510	920	923	SRA	Gene	4481
37298510	1083	1104	cognitive dysfunction	Disease	MESH:D003072
37298510	1120	1122	AD	Disease	MESH:D000544
37298510	1174	1208	ethylcholine mustard azirinium ion	Chemical	-
37298510	1210	1215	AF64A	Chemical	MESH:C044894
37298510	1264	1282	memory dysfunction	Disease	MESH:D008569
37298510	1305	1309	HMO6	CellLine	CVCL:5G94
37298510	1341	1345	mice	Species	10090
37298510	1354	1365	memory loss	Disease	MESH:D008569
37298510	1377	1382	AF64A	Chemical	MESH:C044894
37298510	1424	1427	ACh	Chemical	MESH:D000109
37298510	1501	1508	F3.ChAT	CellLine	CVCL:B1NB
37298510	1510	1518	HMO6.NEP	CellLine	CVCL:5G94
37298510	1523	1531	HMO6.SRA	CellLine	CVCL:5G94
37298510	1581	1586	mouse	Species	10090
37298510	1731	1739	HMO6.NEP	Gene	4311
37298510	1743	1751	HMO6.SRA	CellLine	CVCL:5G94
37298510	1814	1819	AF64A	Chemical	MESH:C044894
37298510	1831	1835	mice	Species	10090
37298510	1881	1884	ACh	Chemical	MESH:D000109
37298510	1918	1930	inflammatory	Disease	MESH:D007249
37298510	1943	1974	glial fibrillary acidic protein	Gene	2670
37298510	2095	2099	ChAT	Gene	1103
37298510	2101	2104	NEP	Gene	4311
37298510	2108	2111	SRA	Gene	4481
37298510	2170	2172	AD	Disease	MESH:D000544
37298510	Positive_Correlation	MESH:C044894	MESH:D008569
37298510	Association	MESH:D000109	1103
37298510	Association	MESH:D000109	MESH:D000544
37298510	Association	MESH:D000544	43

